Segulah V
Finance · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Stureplan Stockholm 3, Stockholm, Stockh...Phone Number
+46 84028700Website
www.segulah.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Segulah V
Segulah Medical Acceleration (SMA) is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe. SMA's objective is to help its partner companies accelerate growth and reach commercial proof of concept. SMA's geographic remit is Scandinavia and other Western European countries. The areas within Medtech that SMA prioritizes include medical devices and consumables, diagnostics, life science tools, and digital technologies (AI).Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Segulah V your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Segulah V, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Segulah V has new funding data
Product Launch: Get notified when Segulah V launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Segulah V is spiking on competitors!
Click to see if Segulah V had a recent Job posting/layoffs
Check if Segulah V has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Segulah V
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Segulah V recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Segulah V as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Segulah V is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Segulah V is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Segulah V.
Segulah V Tech Stack
A closer look at the technologies used by Segulah V
See more technologies
Segulah V News & Media
Signifier Medical Technologies Announces $49MM Purchase of Existing Shares by Waha Capital, Angelus Sano Ventures and Segulah Medical Acceleration
BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that Waha Capital PJSC (“Waha Capital”), Angelus Sano Fund L.P. (“Angelus”), Segulah Medical Acceleration AB (“Segulah Medical”) and certain other individual investors have collectively invested approximately $49 million in the purchase of existing shares in the Company from shareholders unrelated to the Board and Management. Signifier is the developerSegulah Medical Acceleration invests in Signifier Medical Technologies
Segulah Medical Acceleration invests in Signifier Medical Technologies Submitted 30/07/2021 - 9:26am Segulah Medical Acceleration AB (SMA) has invested in UK-based Signifier Medical Technologies’ USD35 million Series D convertible financing. The financing was jointly led by SMA together with Angelus Venture Fund I LP, Alan Howard (co-founder of Brevan Howard Asset Management) and Pioneer Healthcare Partners LP. Signifier is commercialising proprietary technologies to address the root causes of sBlue chip investors back new MedTech investment company
Segulah Medical Acceleration, SMA, is a newly formed company specializing in medical technology investments, with a focus on Sweden, Scandinavia and Western Europe. The company is financed by leading institutions and prominent private investors, whose initial commitments amount to approximately SEK 1.2 billion. The initiator behind Segulah Medical Acceleration is Gabriel Urwitz, founder of Nordic private equity fund group Segulah. SMA is an investment company, whose objective is to help young, iSegulah to acquire Swedish rail company NVBS Rail
1st Apr 2020 - 3:42pm Segulah to acquire Swedish rail company NVBS Rail Submitted 01/04/2020 - 3:42pm Segulah Fund V is to acquire a majority stake in NVBS Rail, to support the company's growth. The acquisition will be the tenth investment for Segulah Fund V. NVBS founders David and Daniel Skalin, as well as minority shareholders will retain a significant shareholding in the company following the deal. Founded in 2012 by brothers David and Daniel
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Segulah V
Sign Up For FreeTo access detailed company insights
Segulah Medical Acceleration (SMA) is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe. SMA's objective is to help its partner companies accelerate growth and reach commercial proof of concept. SMA's geographic remit is Scandinavia and other Western European countries. The areas within Medtech tha... Read More
